The Hindu Business Line : MSD Pharma's new diabetic drug

MSD Pharmaceuticals Ltd, the wholly-owned subsidiary of Merck & Co Inc has launched its patented medicine for diabetic care under the brand name `Januvia'. The company said it was aiming four per cent market share in the domestic pharmaceutical segment by 2015. The MSD Pharma Managing Director, Dr Naveen Rao, said it was also planning to launch four more drugs used in therapeutic area of diabetes, dyslipidimia, cervical cancer and diarrhoea. The company is awaiting the approval from the Drug Controller General of India (DCGI) to launch more products in the country. "We have plans to launch one new medicine in a period of every six months for the next two-three years in the country," Mr Rao said. The drug maker also plans to double its workforce in India from the current 400 to 800 by the end of the current year. - Our Bureau

More Stories on : New Products & Services | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
BHEL to spend Rs 500 cr on R&D

Lupin adds to Suprax basket in US

Indoco changes financial year end

Monnet Ispat announces 25% interim

Shifts in business segments account for major growth in cos, says McKinsey

‘Reliance KG fields may go on stream by Aug’

Changes likely in depreciation norms for infrastructure projects

Srei building photovoltaic factory, power plant at Haldia

J.G. Hosiery on expansion mode

Berger Paints set to acquire Polish firm for $38.6 m

Tighten your belts, PM tells corporates

Mahindra plans ultra low-cost rural tractor

Issue of shares to foreign cos may be allowed against payment made to third party

MSD Pharma's new diabetic drug